Larimar Therapeutics, Inc. - LRMR
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Mar 02, 2026 | — | P | A | 5,000.0 | 5.0 | 25,000.0 | 5,000.0 | View | |
| Mar 02, 2026 | — | P | A | 5,000.0 | 5.0 | 25,000.0 | 7,000.0 | View | |
| Mar 02, 2026 | — | P | A | 100,000.0 | 5.0 | 500,000.0 | 664,798.0 | View | |
| Mar 02, 2026 | — | P | A | 2,000,000.0 | 5.0 | 10,000,000.0 | 6,207,982.0 | View | |
| Mar 02, 2026 | — | P | A | 831,978.0 | 5.0 | 4,159,890.0 | 8,153,107.0 | View | |
| Mar 02, 2026 | — | P | A | 1,084,012.0 | 5.0 | 5,420,060.0 | 10,622,957.0 | View | |
| Mar 02, 2026 | — | P | A | 1,084,010.0 | 5.0 | 5,420,050.0 | 10,622,928.0 | View | |
| Jan 27, 2026 | President and CEO | A | A | 600,600.0 | 0.0 | 0.0 | 600,600.0 | View | |
| Jan 27, 2026 | President and CEO | A | A | 100,100.0 | 0.0 | 0.0 | 368,276.0 | View | |
| Jan 27, 2026 | Chief Medical Officer | A | A | 153,822.0 | 0.0 | 0.0 | 153,822.0 | View | |
| Jan 27, 2026 | Chief Medical Officer | A | A | 25,637.0 | 0.0 | 0.0 | 71,443.0 | View | |
| Jan 27, 2026 | Chief Development Officer | A | A | 153,822.0 | 0.0 | 0.0 | 153,822.0 | View | |
| Jan 27, 2026 | Chief Development Officer | A | A | 25,637.0 | 0.0 | 0.0 | 76,443.0 | View | |
| Jan 27, 2026 | Chief Financial Officer | A | A | 225,622.0 | 0.0 | 0.0 | 225,622.0 | View | |
| Jan 27, 2026 | Chief Financial Officer | A | A | 37,604.0 | 0.0 | 0.0 | 215,785.0 | View |